Effect of p53 Arg72Pro polymorphism on the induction of micronucleus by aflatoxin B1 in in vitro in human blood lymphocytes

References

• Aslan A, Agar G, Alpsoy L, et al (2012). Protective role of methanol extracts of two lichens on oxidative and genotoxic damage caused by AFB1 in human lymphocytes in vitro. Toxicol Ind Health 28:505–512
   PubMed Web of Science ®Google Scholar
• Bolognesi C, Abbondandolo A, Barale R, et al (1997). Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev 6:249–256
   PubMed Web of Science ®Google Scholar
• Bonassi S, Znaor A, Ceppi M, et al (2007). An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625–631
   PubMed Web of Science ®Google Scholar
• Buchman VL, Chumakov PM, Ninkina NN, et al (1998). A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245–252
   Web of Science ®Google Scholar
• Chipuk JE, Kuwana T Bouchier-Hayes L, et al (2004). Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010–1014
   PubMed Web of Science ®Google Scholar
• Dahabreh IJ, Linardou H, Bouzika P, et al (2010). TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 19:1840–1847
   PubMed Web of Science ®Google Scholar
• Dumont P, Leu JI, Della Pietra IIIAC, et al (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365
   PubMed Web of Science ®Google Scholar
• Fenech M. (2000). The in vitro micronucleus technique. Mutat Res 455:81–95
   PubMed Web of Science ®Google Scholar
• Fenech M, Chang WP, Kirsch-Volders M, et al (2003). HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65–75
   PubMed Web of Science ®Google Scholar
• Fenech M, Holland N, Chang WP, et al (1999). The Human MicroNucleus Project – an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 428:271–283
   PubMed Web of Science ®Google Scholar
• Fenech M, Morley AA. (1985). Measurement of micronuclei in lymphocytes. Mutat Res 147:29–36
   PubMed Web of Science ®Google Scholar
• Godderis L, Aka P, Mateuca R, et al (2006). Dose-dependent influence of genetic polymorphisms on DNA damage induced by styrene oxide, ethylene oxide and gamma-radiation. Toxicology 219:220–229
   PubMed Web of Science ®Google Scholar
• Gross-Steinmeyer K, Eaton DL. (2012). Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1). Toxicology 299:69–79
   PubMed Web of Science ®Google Scholar
• Hagmar L, Bonassi S, Strömberg U, et al (1998). Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117–4121
   PubMed Web of Science ®Google Scholar
• Harris N, Brill E, Shohat O, et al (1986). Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6:4650–4656
   PubMed Web of Science ®Google Scholar
• IARC. (1987). IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. Suppl. 7, 440
   Google Scholar
• Iarmarcovai G, Ceppi M, Botta A, et al (2008). Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutat Res 659:274–283
   PubMed Web of Science ®Google Scholar
• Ji F, Wang W, Xia ZL, et al (2010). Prevalence and persistence of chromosomal damage and susceptible genotypes of metabolic and DNA repair genes in Chinese vinyl chloride-exposed workers. Carcinogenesis 31:648–653
   PubMed Web of Science ®Google Scholar
• Jiang DK, Yao L, Wang WZ, et al (2011). TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. World J Gastroenterol 17:1227–1233
   PubMed Web of Science ®Google Scholar
• Kirsch-Volders M, Sofuni T, Aardema M, et al (2003). Report from the in vitro micronucleus assay working group. Mutat Res 540:153–163
   PubMed Web of Science ®Google Scholar
• Leu JI, Dumont P, Hafey M, et al (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6:443–450
   PubMed Web of Science ®Google Scholar
• Levine AJ. (1997). p53, the cellular gatekeeper for growth and division. Cell 88:323–331
   PubMed Web of Science ®Google Scholar
• Li Y, Feng NN, Zhang GH, et al (2013). Polymorphisms in the p53 pathway genes and micronucleus occurrence in Chinese vinyl chloride-exposed workers. Int J Occup Med Environ Health 26:825–836
   PubMed Web of Science ®Google Scholar
• Manfredi S, Masetti S, Botto N, et al (2002). P53 codon 72 polymorphism in coronary artery disease: no evidence for association with increased risk or micronucleus frequency. Environ Mol Mutagen 40:110–115
   PubMed Web of Science ®Google Scholar
• Maron DM, Ames BN. (1983). Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215
   PubMed Web of Science ®Google Scholar
• Matlashewski GJ, Tuck S, Pim D, et al (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol. 7:961–963
   PubMed Web of Science ®Google Scholar
• Murphy ME. (2006). Polymorphic variants in the p53 pathway. Cell Death Differ 13:916–920
   PubMed Web of Science ®Google Scholar
• Norppa H. (1997). Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ Health Perspect 105:829–835
   PubMed Web of Science ®Google Scholar
• Pereira L, Carvalho MR, Fonseca CG, et al (2011). Influence of Arg72Pro polymorphisms of TP53 on the response of buccal cells to radiotherapy. Genet Mol Res 10:3552–3558
   PubMed Web of Science ®Google Scholar
• Pim D, Banks L. (2004). p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108:196–199
   PubMed Web of Science ®Google Scholar
• Qiu YL, Wang W, Wang T, et al (2008). Genetic polymorphisms, messenger RNA expression of p53, p21, and CCND1, and possible links with chromosomal aberrations in Chinese vinyl chloride-exposed workers. Cancer Epidemiol Biomarkers Prev 17:2578–2584
   PubMed Web of Science ®Google Scholar
• Ren WH, Jiang DK, Pei Y, et al (2014). Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies. Genet Mol Res 13:103–114
   PubMed Web of Science ®Google Scholar
• Rodriguez S, Gaunt TR, Day IN. (2009). Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169:505–514
   PubMed Web of Science ®Google Scholar
• Shen SQ, Jiang DK, Liu GY, et al (2012). Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk. Mol Biol Rep 39:4683–4690
   PubMed Web of Science ®Google Scholar
• Siddique M, Sabapathy K. (2006). Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 25:3489–3500
   PubMed Web of Science ®Google Scholar
• Sümbül AT, Akkız H, Bayram S, et al (2012). p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep 39:1639–1647
   PubMed Web of Science ®Google Scholar
• Tang W, He X, Chan Y, Luo Y. (2012). Lack of association between p53 codon 72 polymorphism and endometrial cancer: a meta-analysis. Cancer Epidemiol 36:e153–e157
   Google Scholar
• Thomas M, Kalita A, Labrecque S, et al (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092–1100
   PubMed Web of Science ®Google Scholar
• Türkez H, Sişman T. (2007). Anti-genotoxic effect of hydrated sodium calcium aluminosilicate on genotoxicity to human lymphocytes induced by aflatoxin B1. Toxicol Ind Health 23:83–89
   PubMed Web of Science ®Google Scholar
• Wang F, Wang P, Wang B, et al (2014). Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk. Tumour Biol 35:2723–2728
   PubMed Web of Science ®Google Scholar
• Whibley C, Pharoah PD, Hollstein M. (2009). p53 polymorphisms: cancer implications. Nat Rev Cancer 9:95–107
   PubMed Web of Science ®Google Scholar
• Xiang B, Mi YY, Li TF, Liu PF. (2012). Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk. Asian Pac J Cancer Prev 13:1787–1791
   PubMedGoogle Scholar
• Xu CT, Zheng F, Dai X, et al (2012). Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis. Asian Pac J Cancer Prev 13:4305–4309
   PubMedGoogle Scholar
• Yan L, Zhang D, Chen C, et al (2009). TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis. Int J Cancer 125:2903–2911
   PubMed Web of Science ®Google Scholar
• Zhu W, Lu L, Li Y, et al (2014). The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis. Tumour Biol 35:3725–3730
   PubMed Web of Science ®Google Scholar